O'Reilly logo

The Funding of Biopharmaceutical Research and Development by D. R. Williams

Stay ahead with the world's most comprehensive technology and business learning platform.

With Safari, you learn the way you learn best. Get unlimited access to videos, live online training, learning paths, books, tutorials, and more.

Start Free Trial

No credit card required

7

The initial public offering

Abstract:

This chapter examines the initial public offerings in the biopharmaceutical market sector. It focuses on U.S. firms that have gone public and offers insight into other markets. After giving a brief history of stock exchanges, it looks at the process of selling securities on a public exchange for the first time. It examines the role that underwriters (investment banks) play in bringing a security to market. The chapter looks at the costs of becoming a publicly traded firm and shows trends in this market and the effect of an IPO on the firm and its management. The chapter also examines the financial condition of firms that have gone public and historical trends related to stock price and net proceeds.

With Safari, you learn the way you learn best. Get unlimited access to videos, live online training, learning paths, books, interactive tutorials, and more.

Start Free Trial

No credit card required